LeonaBio, Inc. cotiza a 6.16 USD y tiene una capitalización bursátil de $58M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapi…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-1.73 | $-18.92 | $-1.68 |
| Estimado | $-1.36 | $-2.50 | $-1.27 | $-1.22 |
| Sorpresa | — | +30.8% | -1389.8% | -37.7% |
| Métrica | LONA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -380.0% | -40.4% | -339.6% |
| ROA | -114.6% | -32.0% | -82.6% |
| Current Ratio | 1.88 | 2.84 | -0.96 |
| Debt / Equity | — | 0.28 | — |